- June 3, 2022
- Category: What's New
June, 2022 – By Lisa Chamoff
Manufacturers in the PET and SPECT space are focusing on decreasing scan times, improving image quality to see smaller irregularities and lowering ra-diation dose.
In nuclear medicine, product develop-ment has also focused on researching new radiotracers. There are also several preclinical devices in the research stages. Here’s a look at what’s new and what’s to come in the future.
DOSIsoft has been marketing its PLANET Onco Dose software for molecular imag-ing and molecular radiotherapy to provide patient-specific dosimetry, personalization of treatment and disease follow-up. The company has approval to use the software for SIRT/Yttrium-90 in the U.S., and is adding Lutetium-177 and Iodine-131 sup-port in both the U.S. and Europe.
The software is unique in that it’s multi-ra-dionuclides and vendor-neutral, said Sébas-tien Vauclin, product manager at DOSIsoft. “We wanted to have a complete solution that is independent of imaging manufactur-ers,” Vauclin said.